Chiral resolution methods for racemic pharmaceuticals based on cocrystal formation

Literature Information

Publication Date 2023-10-16
DOI 10.1039/D3CE00853C
Impact Factor 3.545
Authors


View Original

Abstract

Currently, more than half of available drugs on the market are chiral, and approximately 90% of these drugs are marketed as racemates. When these racemic medications are exposed to the chiral environment of the human body, differences in their activity appear. The enantiomers of a chiral drug may potentially have distinct pharmacokinetic, metabolic, and toxicological features. As a result, regulatory requirements promote the production of enantiopure drugs to reduce the complexity of pharmacodynamics and the administration dose or to eliminate unwanted side effects, while also providing some economic savings by enabling a totally effective pharmaceutical formulation. There are a variety of procedures employed in the pharmaceutical industry for chiral separation of racemic drugs, such as developing de novo enantiomerically pure pharmaceuticals by asymmetric synthesis or chiral resolution of currently available racemic compounds via different approaches like chiral chromatography methods, diastereoisomeric salt formation, and cocrystallization-based methods. This review will focus on cocrystallization techniques such as the generation of host–guest inclusion compounds, diastereomeric cocrystal pairs, enantiospecific cocrystals, conglomerates, ionic cocrystals, and preferential enrichment of cocrystals. Overall, this review outlined the crucial importance of pharmaceutical cocrystals in chiral resolution techniques of racemic compounds.

Related Literature

Solvothermal synthesis of N-doped TiO2nanotubes for visible-light-responsive photocatalysis

Fan Yang, Nianjun Luo, Bryan T. T. Chu, Deyin Sun, Huahong Shi, Tiancun Xiao, Peter P. Edwards

2008-11-04 Communication

DOI: 10.1039/B815430A

Epoxy functionalised poly(ε-caprolactone): synthesis and application

Jiaxiang Zhou, Wenxin Wang, Silvia Villarroya, Kristofer J. Thurecht, Steven M. Howdle

2008-10-01 Communication

DOI: 10.1039/B810297J

Morphological changes in the self-assembly of a radial oligo-phenylene ethynylene amphiphilic system

Gustavo Fernández, Fátima García, Luis Sánchez

2008-11-12 Communication

DOI: 10.1039/B818378C

Back matter

Front/Back Matter

DOI: 10.1039/B818510G

Light-activation of gene function in mammalian cells viaribozymes

Douglas D. Young, R. Aaron Garner, Jeffrey A. Yoder, Alexander Deiters

2008-12-02 Communication

DOI: 10.1039/B819375D

Relaxation rates for spirocyclohexyl nitroxyl radicals are suitable for interspin distance measurements at temperatures up to about 125 K

Velavan Kathirvelu, Christopher Smith, Christopher Parks, Md. Abdul Mannan, Yozo Miura, Keizo Takeshita, Sandra S. Eaton, Gareth R. Eaton

2008-11-25 Communication

DOI: 10.1039/B817758A

Versatile one-step introduction of multiple hydrogen-bonding sites onto extended π-conjugated systems

Fu-Chuan Fang, Cheng-Che Chu, Chih-Hao Huang, Guillaume Raffy, André Del Guerzo, Ken-Tsung Wong, Dario M. Bassani

2008-11-06 Communication

DOI: 10.1039/B813704H

Controlled self-sorting in the assembly of ‘multi-gelator’ gels‡

Jamie R. Moffat, David K. Smith

2008-11-19 Communication

DOI: 10.1039/B818058J

Tin triflate-mediated total synthesis of circumdatin F, sclerotigenin, asperlicin C, and other quinazolino[3,2-a][1,4]benzodiazepines

Ming-Chung Tseng, Chi-Yu Lai, Yu-Wan Chu, Yen-Ho Chu

2008-11-19 Communication

DOI: 10.1039/B813880J

An unprecedented lanthanide phosphinidene halide: synthesis, structure and reactivity

Peng Cui, Yaofeng Chen, Xin Xu, Jie Sun

2008-09-24 Communication

DOI: 10.1039/B813075B

You might also like

Compound Q&A

What is Ethyl 3-cyclohexylpropanoate (CAS: 10094-36-7)?

Ethyl 3-cyclohexylpropanoate is a clear, colorless to light yellow liquid with a...

10094-36-7Ethyl 3-cyclohexylpr...
Compound Q&A

How should waste containing 2-(Hydroxymethyl)-5-(methoxycarbonyl)-6-methyl-4-(2-nitrophenyl)nicotinic acid (CAS: 34783-31-8) be handled?

Waste containing 2-(Hydroxymethyl)-5-(methoxycarbonyl)-6-methyl-4-(2-nitrophenyl...

34783-31-82-(Hydroxymethyl)-5-...
Compound Q&A

How should waste containing 2,4,6-Tris(pentafluoroethyl)-1,3,5-triazine (CAS: 858-46-8) be handled?

Waste containing 2,4,6-Tris(pentafluoroethyl)-1,3,5-triazine (CAS: 858-46-8) sho...

858-46-82,4,6-Tris(pentafluo...
Compound Q&A

What precautions should be taken when handling Chloroac-nle-oh (CAS: 56787-36-1)?

When handling Chloroac-nle-oh (CAS: 56787-36-1), it is essential to wear appropr...

56787-36-1Chloroac-nle-oh
Compound Q&A

What industries use Ethyl 6-phenylimidazo[2,1-b][1,3]thiazole-3-carboxylate (CAS: 752244-05-6)?

Ethyl 6-phenylimidazo[2,1-b][1,3]thiazole-3-carboxylate is primarily used in the...

752244-05-6Ethyl 6-phenylimidaz...
Compound Q&A

Are there alternatives to alpha-(2-Bromophenyl)benzylamine (CAS: 55095-15-3) in synthesis?

Alternatives to alpha-(2-Bromophenyl)benzylamine (CAS: 55095-15-3) in synthesis ...

55095-15-3alpha-(2-Bromophenyl...
Compound Q&A

How should waste containing 2-Chloro-5-methoxypyridine (CAS: 139585-48-1) be handled?

Waste containing 2-Chloro-5-methoxypyridine (CAS: 139585-48-1) should be managed...

139585-48-12-Chloro-5-methoxypy...
Compound Q&A

What industries use 1-(4-Methoxyphenyl)-2,5-dimethyl-1H-pyrrole (CAS: 5044-27-9)?

1-(4-Methoxyphenyl)-2,5-dimethyl-1H-pyrrole (CAS: 5044-27-9) is used in various ...

5044-27-91-(4-Methoxyphenyl)-...
Compound Q&A

Are there alternatives to 3-Bromo-5-(N-Boc)aminomethylisoxazole (CAS: 903131-45-3) in synthesis?

There are alternative reagents and compounds that can be used in the synthesis o...

903131-45-33-Bromo-5-(N-Boc)ami...
Compound Q&A

What is Tungsten(IV) oxide (CAS: 12036-22-5)?

Tungsten(IV) oxide, also known as tungsten dioxide, is a chemical compound with ...

12036-22-5Tungsten(IV) oxide

Source Journal

CrystEngComm

CrystEngComm
CiteScore: 5.5
Self-citation Rate: 7.7%
Articles per Year: 643

CrystEngComm is the forum for the design and understanding of crystalline materials. We welcome studies on the investigation of molecular behaviour within crystals, control of nucleation and crystal growth, engineering of crystal structures, and construction of crystalline materials with tuneable properties and functions. We publish hypothesis-driven research into… how crystal design affects thermodynamics, phase transitional behaviours, polymorphism, morphology control, solid state reactivity (crystal-crystal solution-crystal, and gas-crystal reactions), optoelectronics, ferroelectric materials, non-linear optics, molecular and bulk magnetism, conductivity and quantum computing, catalysis, absorption and desorption, and mechanical properties. Using Techniques and methods including… Single crystal and powder X-ray, electron, and neutron diffraction, solid-state spectroscopy, spectrometry, and microscopy, modelling and data mining, and empirical, semi-empirical and ab-initio theoretical evaluations. On crystalline and solid-state materials. We particularly welcome work on MOFs, coordination polymers, nanocrystals, host-guest and multi-component molecular materials. We also accept work on peptides and liquid crystals. All papers should involve the use or development of a design or optimisation strategy. Routine structural reports or crystal morphology descriptions, even when combined with an analysis of properties or potential applications, are generally considered to be outside the scope of the journal and are unlikely to be accepted.

Recommended Compounds

Recommended Suppliers

Disclaimer
This page provides academic journal information for reference and research purposes only. We are not affiliated with any journal publishers and do not handle publication submissions. For publication-related inquiries, please contact the respective journal publishers directly.
If you notice any inaccuracies in the information displayed, please contact us at support@chemtradehub.com. We will promptly review and address your concerns.